9 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 30.2% per year over the past 5 years.
Net income has grown slower than revenue (4.7% vs 30.2% per year).
Operating margin has expanded, at 6.6% in the latest year.
Free cash flow has grown 40.4% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$1.3B
$59M
23.6%
6.6%
$192M
—
$112M
2024
$1.2B
$54M
21.7%
5.8%
$174M
—
$162M
2023
$1.1B
$62M
21.9%
5.7%
$185M
—
$97M
2022
$787M
$30M
21.3%
3.0%
$77M
—
$120M
2021
$501M
$66M
22.4%
6.5%
$24M
—
$91M
2020
$345M
$46M
20.3%
2.4%
$35M
—
$70M
2019
—
-$9M
—
—
-$4M
—
$80M
2018
—
$661000
—
—
$2M
—
$127000
2017
—
-$12M
—
—
-$10M
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$329M
$24M
25.3%
10.8%
$40M
—
$132M
Dec '25
$318M
$12M
24.1%
4.8%
$49M
—
$112M
Sep '25
$313M
$14M
23.2%
6.9%
$46M
—
$134M
Jun '25
$333M
$17M
23.7%
7.3%
$50M
—
$133M
Mar '25
$324M
$15M
23.4%
7.5%
$47M
—
$109M
Dec '24
$298M
$11M
21.3%
5.3%
$50M
—
$162M
Sep '24
$287M
$10M
20.7%
4.3%
$43M
—
$91M
Jun '24
$304M
$16M
22.5%
6.8%
$56M
—
$95M
Mar '24
$278M
$17M
22.4%
6.7%
$25M
—
$115M
Dec '23
$270M
$13M
21.1%
5.1%
$37M
—
$97M
Sep '23
$281M
$16M
22.3%
6.5%
$53M
—
$158M
Jun '23
$279M
$15M
21.7%
5.4%
$75M
—
$171M
Mar '23
$258M
$18M
22.7%
5.8%
$20M
—
$155M
Dec '22
$214M
$3M
20.8%
1.5%
$51M
—
$120M
Sep '22
$205M
$13M
22.4%
5.5%
$20M
—
$73M
Jun '22
$195M
$9M
22.5%
4.5%
$19M
—
$55M
Mar '22
$172M
$5M
19.1%
-0.0%
-$12M
—
$39M
Dec '21
$128M
$15M
19.7%
-0.1%
$8M
—
$91M
Sep '21
$122M
$17M
23.3%
7.4%
$23M
—
$92M
Jun '21
$129M
$19M
23.0%
9.1%
-$8M
—
$49M
Valuation over time
How the market has priced PGNY against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 83.8× (Mar '23) to 36.6× (Jun '26).
The price-to-sales ratio has fallen from 3.2× (Mar '23) to 1.7× (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is PGNY growing its revenue and profit?
Over the past 5 years, Progyny, Inc.'s revenue has grown 30.2% per year, and net income grown 4.7% per year. These are computed facts, not advice.
How much debt does PGNY have?
As of FY2025, Progyny, Inc. reported — of total debt against $112M of cash.
What is PGNY's profit margin?
In FY2025, gross margin was 23.6%, operating margin 6.6%, and net margin 4.5%.
What is PGNY's P/E ratio?
As of Jun '26, Progyny, Inc. traded at a price-to-earnings ratio of about 36.6× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.